Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Rajiv Kumar & P. Mishra. (2007) Bi(V) organic framework in an asymmetric system: Synthesis, spectroscopic, XRPD and molecular modeling. Main Group Chemistry 6:2, pages 85-95.
Read now
Read now
R. Williamson, G. A. Pipkin, J. R. Wood. (1998) New Options in Helicobacter pylori Eradication: Efficacy, Resistance and Synergy. Scandinavian Journal of Gastroenterology 33:225, pages 36-40.
Read now
Read now
D. Rothenbacher, G. Bode, G. Adler & H. Brenner. (1997) Use of Commonly Prescribed Antibiotics Is Not Associated with Prevalence of Helicobacter pylori Infection in Adults. Scandinavian Journal of Gastroenterology 32:11, pages 1096-1099.
Read now
Read now
C. B. H. W. Lamers. (1995) Closing Remarks H2-Receptor Antagonists and Helicobacter pylori Eradication. Scandinavian Journal of Gastroenterology 30:sup212, pages 126-127.
Read now
Read now
Articles from other publishers (23)
Dafr Allah Benajah, Mounia Lahbabi, Samia Alaoui, Karima El Rhazi, Mohammed El Abkari, Chakib Nejjari, Afaf Amarti, Bahia Bennani, Mustapha Mahmoud & Sidi Adil Ibrahimi. (2013) Prevalence of Helicobacter pylori and its recurrence after successful eradication in a developing nation (Morocco). Clinics and Research in Hepatology and Gastroenterology 37:5, pages 519-526.
Crossref
Crossref
Yan Jin, PeiXue Ling, YanLi He, Lei Chen, JianYing Chen & TianMin Zhang. (2008) Preparation, characterization and anti-Helicobacter pylori activity of Bi3+-hyaluronate complex. Carbohydrate Polymers 74:1, pages 50-58.
Crossref
Crossref
Yelda Leal-Herrera, Javier Torres, Thomas P. Monath, Irma Ramos, Alejandro Gomez, Armando Madrazo-de la Garza, Margarita Dehesa-Violante & Onofre Munoz. (2003) High rates of recurrence and of transient reinfections of Helicobacter pylori in a population with high prevalence of infection. The American Journal of Gastroenterology 98:11, pages 2395-2402.
Crossref
Crossref
Jaime Natan Eisig, Fernando Marcuz Silva, Cláudio Hashimoto, Ethel Zimberg Chehter & Antonio Atilio Laudanna. (2003) Therapeutic efficacy of ranitidine bismuth citrate with clarithromycin for seven days in the eradication of Helicobacter pylori in Brazilian peptic ulcer patients. Sao Paulo Medical Journal 121:1, pages 15-18.
Crossref
Crossref
S. J. Sontag, S. O'Connell, T. Schnell, G. Chejfec, J. Seidel & A. Sonnenberg. (2001) Reduced Symptoms and Need for Antisecretory Therapy in Veterans 3 Years After Helicobacter pylori Eradication With Ranitidine Bismuth Citrate/Amoxicillin/Clarithromycin. American Journal of Gastroenterology 96:5, pages 1390-1395.
Crossref
Crossref
James G. Fox & Robert P. Marini. (2001) Helicobacter mustelae infection in ferrets: Pathogenesis, epizootiology, diagnosis, and treatment. Seminars in Avian and Exotic Pet Medicine 10:1, pages 36-44.
Crossref
Crossref
Luis Bujanda, Carmen Muñoz, Araceli Sánchez, Carmen Iriondo & Angel Cosme. (2000) Ranitidine Bismuth Citrate Plus Azithromycin for Helicobacter pylori Eradication. Journal of Clinical Gastroenterology 30:3, pages 337-338.
Crossref
Crossref
Gina Martino, Marco Paoletti, Adriana Marcheggiano, Giancarlo D'ambra, Gianfranco Delle Fave & Bruno Annibale. (2001)
Duodenal Ulcer Relapse Is Not Always Associated with Recurrence of
H. pylori
Infection: A Prospective Three‐Year Follow‐Up Study
. Helicobacter 4:4, pages 213-217.
Crossref
Crossref
Paré, Farley, Romãozinho, Bardhan, French & Roberts. (2001)
Comparison of ranitidine bismuth citrate plus clarithromycin with omeprazole plus clarithromycin for the eradication of
Helicobacter pylori
. Alimentary Pharmacology & Therapeutics 13:8, pages 1071-1078.
Crossref
Crossref
Giuseppe RealdiMaria P. Dore, Andrea Piana, Antonella AtzeiMonica CartaLuigi CugiaAlessandra Manca, Bianca M. Are, Giovanni Massarelli, Ida Mura, Alessandro Maida & David Y. Graham. (2002)
Pretreatment Antibiotic Resistance in
Helicobacter pylori
Infection: Results of Three Randomized Controlled Studies
. Helicobacter 4:2, pages 106-112.
Crossref
Crossref
Maria P. Dore, Michael S. Osato, Giuseppe Realdi, Ida Mura, David Y. Graham & Antonia R. Sepulveda. (1999) Amoxycillin tolerance in Helicobacter pylori. Journal of Antimicrobial Chemotherapy 43:1, pages 47-54.
Crossref
Crossref
R.P. Marini & J.G. Fox. 1999. Handbook of Animal Models of Infection. Handbook of Animal Models of Infection
273
284
.
Vicente Rodilla, Adrian T. Miles, William Jenner & Gabrielle M. Hawksworth. (1998) Exposure of cultured human proximal tubular cells to cadmium, mercury, zinc and bismuth: toxicity and metallothionein induction. Chemico-Biological Interactions 115:1, pages 71-83.
Crossref
Crossref
K D Bardhan, H Wurzer, M Marcelino, J Jahnsen, N Lotay & P M Roberts. (1998) Ranitidine Bismuth Citrate With Clarithromycin Given Twice Daily Effectively Eradicates Helicobacter pylori and Heals Duodenal Ulcers. American Journal of Gastroenterology 93:3, pages 380-385.
Crossref
Crossref
G. Treiber, S. Ammon, E. Schneider & U. Klotz. (2001)
Amoxicillin/Metronidazole/Omeprazole/Clarithromycin: A New, Short Quadruple Therapy for
Helicobacter pylori
Eradication
. Helicobacter 3:1, pages 54-58.
Crossref
Crossref
Hazel M. Mitchell, Pinjin Hu, Yi Chi, Min Hu Chen, Yu Yuan Li & Stuart L. Hazell. (1998) A low rate of reinfection following effective therapy against Helicobacter pylori in a developing nation (China). Gastroenterology 114:2, pages 256-261.
Crossref
Crossref
A.C.I.T.L. TanG. Den HartogJ.W.R. Meijer, J.E. ThiesR.A. De VriesC.J.J. Mulder. (2008)
No Additional Value of Bismuth Subcitrate to Combination Omeprazole/Amoxicillin Therapy in the Eradication of
Helicobacter pylori
. Helicobacter 2:4, pages 194-198.
Crossref
Crossref
R. J. F. Laheij, J. L. Severens, J. B. M. J. Jansen, E. H. van de Lisdonk & A. L. M. Verbeek. (1997) Management in General Practice of Patients With Persistent Dyspepsia. Journal of Clinical Gastroenterology 25:4, pages 563-567.
Crossref
Crossref
Roy E. PounderJohn W. WyethAnnette E. DugganRobert J. BaileyJapie A. LouwBo Ohlin. (2008)
Ranitidine Bismuth Citrate with Clarithromycin for the Eradication of
Helicobacter pylori
and for Ulcer Healing
. Helicobacter 2:3, pages 132-139.
Crossref
Crossref
Michalis Tzivras, Vasilios Balatsos, Stavros Souyioultzis, Maria Tsirantonaki, Nikolaos Skandalis & Athanasios Archimandritis. (1997) High eradication rate of Helicobacter pylori using a four-drug regimen in patients previously treated unsuccessfully. Clinical Therapeutics 19:5, pages 906-912.
Crossref
Crossref
P DomenicoR J SaloS G NovickP E SchochK Van HornB A Cunha. (1997) Enhancement of bismuth antibacterial activity with lipophilic thiol chelators. Antimicrobial Agents and Chemotherapy 41:8, pages 1697-1703.
Crossref
Crossref
G. Treiber, S. Ammon & U. Klotz. (1997) Age-dependent eradication of Helicobacter pylori with dual therapy. Alimentary Pharmacology and Therapeutics 11:4, pages 711-718.
Crossref
Crossref
T. Breuer, J. G. Kim, I. E. Gurer, D. P. Graham, M. Osato, R. M. Genta & D. Y. Graham. (2003)
Successful low‐dose amoxycillin, metronidazole and omeprazole combination therapy in a population with a high frequency of metronidazole‐resistant
Helicobacter pylori
. Alimentary Pharmacology & Therapeutics 11:3, pages 523-527.
Crossref
Crossref